Chief Executive Officer and Director
Mr. Torres has over 15 years of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions. Mr. Torres was previously head of business development for SNC-Lavalin, Colombia, and was instrumental in growing the company from two people to more than 2,000 people in Colombia over the course of three years. Mr. Torres has overseen the development of projects totaling over $1 billion in capital expenditure, including the development and construction of Colombia’s tallest skyscraper. Mr. Torres holds a Bachelor of Engineering and a Masters of Engineering from Rensselaer Polytechnic Institute and an MBA from Georgetown University.
Mr. Naprawa brings extensive institutional capital markets experience to the Company. Prior to joining Khiron, Mr. Naprawa was Partner at Sprott Capital Partners, Head of Equity Sales at Macquarie Canada, Head of Equity Sales and Trading at Dundee Securities, and Managing Director at Primary Capital. He was also previously founder and CEO of Startcast Solutions, a company successfully sold to a large telecommunications company. Mr. Naprawa holds a Bachelor of Arts from Queen's University.
Chief Financial Officer
Mr. Collins is a financial professional focused on the financial development of growth companies globally. He has been involved in over a billion dollars of transactions, and his expertise spans mergers and acquisitions, debt and equity financings, go-public transactions, commercial partnerships, capital budgeting and financial accounting. Prior to his current activities, Mr. Collins was engaged by investment and merchant banks, including Alegro Capital, LP in London, England, and Scotia Capital Inc. and Quest Capital Corp. (currently Sprott Resource Lending Corp.) in Toronto, Canada. In addition, he was previously Chief Financial Officer of an e-commerce company focused on the global distribution of vaporizers and accessories. Mr. Collins holds a Bachelor of Commerce degree in finance from Dalhousie University.
Juan Diego Alvarez
Vice President Regulatory
Mr. Alvarez has 10 years of legal experience in Colombia and is an authority on Colombian medicinal cannabis regulation. He was previously a public policy advisor to the Ministry of Health in Colombia. In the last five years, Mr. Alvarez has been a consultant for Payson Center for International Development and USAID, a Professor of Law at the University of Los Andes, and VP Regulatory of Khiron Life Sciences Corp. Mr. Alvarez holds an LL.B from the University of Los Andes, a JD from Tulane University, an LL.M from Columbia University and is a PhD law candidate.
Vice President of Business Developments
Andrés Galofre has 15 years of experience in pharmaceutical marketing, brand management and distribution of prescription drugs and consumer products in Latin America. Mr. Galofre was integral in leading the launch of Advil in the Colombian market, which reached a 28% domestic market share. In the last five years, Mr. Galofre has been Marketing Manager for Alpina, Founder of VeggiesBox and VP of Business Development of Khiron Life Sciences Corp. Mr. Galofre has a Bachelor of Business Administration from CESA and an MBA from La Trobe University.
Vice President of Compliance
Mr. Murphy is an executive leader with broad based domestic and international expertise in both the federal and private sectors. As a Career Special Agent (25 years) with the DEA, he served in a multitude of positions prior to founding the Pharma Compliance Group (PCG). Mr. Murphy is an internationally recognized security expert in the fields of drug law enforcement, risk assessment and system development, regulatory compliance, and training. Mr. Murphy will support the Company by implementing closed loop systems to prevent product diversion and to enhance protocols across Khiron's plant to patient value chain.
Maria-Fernanda Arboleda MD
Dr. Maria Fernanda Arboleda is an Anesthesiologist, Pain and Palliative Care Physician. She also completed a Spine-Regional Anesthesia Fellowship at the McGill University Health Center and most recently, she completed a Post-Doctoral Research Fellow in Supportive Cancer Care and Medical Cannabis, at the Department of Oncology, McGill University, and at Santé Cannabis, a leading specialized cannabis clinic in Canada.
Presently, Dr. Arboleda is the Medical Director of Khiron Life Sciences Corp. Likewise, she is a co-investigator on several research projects that are being developed in Canada, including the deployment of a phase II study on the use of cannabis oil capsules for chronic pain, as well as the first phase III study for the use of inhaled cannabis to improve health-related quality of life in advanced cancer patients.
Vice President of Medical Affairs
Jairo Espinoza has over 16 years of medical experience, specializing in stereotactic and functional neurosurgery to help with the control of chronic pain faced by his patients. He is noted for founding the Latin American Institute of Neurology and Nervous System (ILANS) in Colombia which is a network of neurological institutions, providing interdisciplinary diagnosis and treatment of diseases in the nervous system. He is actively involved in the medical community, having served on the Board of Directors for the World Society for Functional and Stereotactic Neurosurgery from 2010 to 2018 and as the President of the Sociedad Latinoamericana de Neurocirugía Funcional y Estereotáctica (SLANFE) from 2010 to 2012.
Vice President of Corporate Development
John is an experienced leader who has been at the forefront of the Canadian and global cannabis sector with 25 years of senior capital markets experience, working as Managing Director and Partner at Beacon Securities. Mr. Cooke has also served as a Senior Managing Partner at Paradigm Capital. In his role as VP of Corporate Development at Khiron, John brings a valuable network to the Company and the ability to build fruitful commercial and capital markets relationships. Based in Toronto, John is a chartered financial analyst and holds an MBA from the Rotman School of Management at the University of Toronto.
Country Manager, Mexico
Luis is a senior executive in the pharmaceutical and health care sector with more than two decades of market experience across Latin America, Luis has an extensive track record with global brands that operate in the region, which include Pfizer and Wyeth. Mr. Chavas also served as a Business Unit head for Novartis Mexico.
Country Manager, Chile
An experienced pharmaceutical industry specialist, Rodrigo Azocar has played an important role in marketing, brand positioning, management, and corporate development for leading pharma organizations in Chile, over a career span of 20+ year. Rodrigo is also current member of the board of ASILFSA, the Chile-based industrial association of pharmaceutical laboratories.
Lead, Dixie Brands Joint Venture
Highly skilled marketing and sales executive, Rodrigo has over 17 years of experience in the consumer goods and pharma industry. His wealth of experience covers directing go-to-market strategies, managing teams, and bringing brands to the consumer market across Latin America. As Consumer Brands Director for Team Foods, Rodrigo was responsible for $70 Million in US sales through retail and digital channels.